Blaenau Gwent Local Health Board Annual General Meeting

1
Blaenau Gwent Local Health Board Annual General
Meeting

• 2007/08
• Financial Summary
• Robert Holcombe Finance Director

2
Overview

• Financial Performance Targets
• Investment profile 2007/08
• Forward look 2008/09

3
Financial Performance Targets

• Ensuring Effective Management of Public Funds
• Targets include
• Achieving Operational financial Balance
  (Statutory Duty)
• Public Sector Payments Policy (Paying Bills
  within 30 days)
• Cash Balance (Must not overdraw)
• Statement of Internal control (demonstrating an
  adequate system of internal control)

4
Performance Achieved 2007/08

• Reported a surplus of 48k ( surplus achieved
  03/04 to 05/06, deficit 06/07)
• Key Points
• Recovery Plan achieved - required savings target
  (1.3m recurring)
• Prescribing savings supported LHB position and
  cost pressures
• Grogan/Continuing Health Care a significant cost
  pressure (1.3m, 33 increase).

5
Performance Achieved 2007/08

• Compliance against Public Sector Payment Policy
  (gt99)
• Achieved Cash management targets
• 946k balance
• Internal Audit Opinion for the year confirmed a
  sound system of internal control
• (subject to out of hours recommendations all
  actions completed July 2008)

6
Performance Achieved 2007/08

• The Audit Opinion given on the Annual Statutory
  Accounts is split into 3 elements
• True Fair View - confirmed
• Prepared in accordance with regulations -
  confirmed
• Expenditure applied as intended by NAW confirmed

7
Investment Profile 2006/07
8
Investment Profile Analysis

• Primary Care
• GMS (GPs) 10m
• Pharmacists 2m
• GP Prescribing 14m
• Dentists 4m
• Optometrists 1m
• Secondary Care
• Gwent Healthcare 66m
• Other Trusts 5m
• Local Authority/Voluntary 1m
• Continuing Care/FNC 7m
• Other 1m

9
Forward Look for 2008/09

• Annual Operating Framework 2008/09
• Treatment waiting time target of 14 weeks
• New Outpatient waiting time target of 10 weeks
• Challenge to achieving financial balance
• FRP to be achieved
• Key Risk Issues
• Funding Waiting Times
• Continuing Health Care Uncertainty
• Drugs Uncertainty